Monday, 5 October 2026Updated 10m ago
← Market pulse
Broker call▲ Bullish for Molbio Diagnostics

Molbio Diagnostics draws Motilal Oswal Buy rating with ₹1,800 target

2 sources · first seen 11:00 5 Oct · updated 11:56 5 Oct

The brief

Written from 2 reports · check the source before you trade
  • Motilal Oswal cited diversification beyond TB, international adoption and improving cash conversion
  • A potential re-rating could benefit Molbio Diagnostics investors, though the reports provide no listed-stock symbol

Tags on this story

Pick a tag to see all its stories
Molbio Diagnostics₹1,513.10 · 2 todayMotilal Oswal Financial Services₹989.90 · 4 todayHospitals4 todayPharma and healthcare15 today

Read the reports

2 reports · earliest 11:00
MoneycontrolBuy Molbio Diagnostics; target of Rs 1800: Motilal Oswal11:00NDTV ProfitMolbio Diagnostics Shares In Focus As Motilal Oswal Initiates Coverage; Check Target Price11:56